Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?

Chemotherapy-induced premature ovarian insufficiency (POI) is one of the potential drawbacks of chemotherapy use of particular concern for newly diagnosed premenopausal breast cancer patients. Temporary ovarian suppression obtained pharmacologically with the administration of a gonadotropin-releasin...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Med Insights Reprod Health
Päätekijät: Lambertini, Matteo, Richard, François, Nguyen, Bastien, Viglietti, Giulia, Villarreal-Garza, Cynthia
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2019
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6410390/
https://ncbi.nlm.nih.gov/pubmed/30886529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179558119828393
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia